The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche Pharma AG
Research Funding - Novartis
Travel, Accommodations, Expenses - MSD Oncology; Novartis; Pierre Fabre
 
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
HORIZON: A French descriptive cohort of 663 patients treated for melanoma with pembrolizumab with a focus on the mucosal subgroup (n=59).
 
Caroline Dutriaux
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Roche
 
Nicolas Meyer
Honoraria - Bristol-Myers Squibb; MSD; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Roche (Inst)
Expert Testimony - Bristol-Myers Squibb; MSD; Roche
Travel, Accommodations, Expenses - Roche
 
Philippe Saiag
No Relationships to Disclose
 
Evelyne Boos
No Relationships to Disclose
 
Catherine Hunault
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Lynda Benmahammed
Employment - Merck; MSD
 
Laurent Mortier
No Relationships to Disclose